Literature DB >> 16989263

Mass immunization programs: principles and standards.

J D Grabenstein1, R L Nevin.   

Abstract

Mass immunization involves delivering immunizations to a large number of people at one or more locations in a short interval of time. Good mass immunization programs apply planning and quality standards that maximize return on resources invested and provide the greatest individual benefits when immunizing many people in a short period of time. These programs can be used to counter contagious outbreaks, adopted as a repeated means of sustained healthcare delivery, or applied where many people move through a specific place in a short interval of time. Relevant quality standards address appropriate facilities and supplies, training of professional and paraprofessional staff, education of potential vaccinees and methods to screen them for contraindications to immunization, safeguards against anaphylaxis and syncope, documentation, safety surveillance, and a quality-improvement program. Successful mass immunization programs require early planning that builds on existing competencies. As the number of available vaccines increases, prioritizing which vaccines to administer during mass campaigns requires consideration of effectiveness, safety, and a cost-benefit equation from both the individual and community perspectives. Mass immunization campaigns aim to maximize the health of a population, but such campaigns need to be customized based on individual contraindications to immunization. Mass immunization programs need to be conducted ethically, with considerations of benefit versus risk and the need for detailed education of healthcare workers and vaccinees.

Entities:  

Mesh:

Year:  2006        PMID: 16989263     DOI: 10.1007/3-540-36583-4_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  4 in total

Review 1.  Vaccination policy in Korean armed forces: current status and future challenge.

Authors:  Jung Yeon Heo; Kang-Won Choe; Chang-Gyo Yoon; Hye Won Jeong; Woo Joo Kim; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

2.  Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance.

Authors:  Timothy H Burgess; Clinton K Murray; Mary F Bavaro; Michael L Landrum; Thomas A O'Bryan; Jessica G Rosas; Stephanie M Cammarata; Nicholas J Martin; Daniel Ewing; Kanakatte Raviprakash; Deepika Mor; Elizabeth R Zell; Kenneth J Wilkins; Eugene V Millar
Journal:  Vaccine       Date:  2015-06-25       Impact factor: 3.641

3.  The comprehensive 'Communicate to Vaccinate' taxonomy of communication interventions for childhood vaccination in routine and campaign contexts.

Authors:  Jessica Kaufman; Heather Ames; Xavier Bosch-Capblanch; Yuri Cartier; Julie Cliff; Claire Glenton; Simon Lewin; Artur Manuel Muloliwa; Afiong Oku; Angela Oyo-Ita; Gabriel Rada; Sophie Hill
Journal:  BMC Public Health       Date:  2017-05-10       Impact factor: 3.295

4.  Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.

Authors:  Anna Ribera-Cano; Maud Dupont; Charles-Henri Houzé-Cerfon; Vanessa Houzé-Cerfon; Alexander Hart; Attila J Hertelendy; Gregory Ciottone; Vincent Bounes
Journal:  Vaccine       Date:  2021-11-03       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.